Trivium Point Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,529
Closed -$232K 189
2022
Q4
$232K Buy
2,529
+11
+0.4% +$1.06K 0.07% 169
2022
Q3
$248K Buy
2,518
+99
+4% +$9.8K 0.08% 164
2022
Q2
$227K Sell
2,419
-446
-16% -$43.5K 0.07% 178
2022
Q1
$292K Sell
2,865
-106
-4% -$11.1K 0.06% 194
2021
Q4
$307K Buy
+2,971
New +$275K 0.06% 193
2021
Q1
Sell
-20,964
Closed -$1.55M 202
2020
Q4
$1.55M Buy
20,964
+815
+4% +$53K 0.45% 82
2020
Q3
$1.18M Buy
20,149
+7,154
+55% +$445K 0.42% 94
2020
Q2
$844K Buy
12,995
+203
+2% +$12.8K 0.33% 98
2020
Q1
$760K Buy
+12,792
New +$854K 0.39% 90

Other funds holding CVS

Trivium Point Advisory's CVS Position: Q1 2023 in Review

Trivium Point Advisory sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,529 shares — an estimated $232K sold.

Trivium Point Advisory first reported a position in CVS in Q1 2020 and held it in 9 quarters. The position peaked at $1.55M in Q4 2020. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Trivium Point Advisory reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Trivium Point Advisory sold 2,529 CVS Health shares in Q1 2023, an estimated $232K.
  • Trivium Point Advisory first reported a position in CVS Health in Q1 2020 and held it in 9 quarters.
  • Trivium Point Advisory's CVS Health position peaked at $1.55M in Q4 2020.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Trivium Point Advisory's 13F filing for Q1 2023, filed 12 Apr 2023.